Skip to main content
Fig. 6 | Arthritis Research & Therapy

Fig. 6

From: Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers

Fig. 6

Prevalence of consensus criteria antiphospholipid antibodies (aPL) tested by line immunoassay (LIA), enzyme-linked immunosorbent assay (ELISA), and lupus anticoagulant (LA) analysis in 61 patients with antiphospholipid syndrome (APS), 24 aPL-positive (aPL+) individuals, and 23 Veneral Disease Laboratory test-positive (VDRL+) patients. aß2GPI antibeta2-glycoprotein I, aCL anticardiolipin, aPA antiphosphatidic acid, aPE antiphosphatidylethanolamine, aPG antiphosphatidylglycerol, aPI antiphosphatidylinositol, aPL+ asymptomatic carriers with autoantibodies to phospholipids, aPS antiphosphatidylserine. *P < 0.05; **p < 0.0001; §not done

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us